Strengthening the prevention and treatment of postoperative hypocalcemia of thyroid cancer patients
10.3760/cma.j.cn115807-20240725-00246
- VernacularTitle:关注甲状腺癌术后低钙血症的防治
- Author:
Xiaochun CHENG
1
;
Lingquan KONG
;
Liyuan MU
;
Jiangyu TU
;
Yuanyuan WANG
;
Kainan WU
Author Information
1. 重庆医科大学附属第一医院乳腺甲状腺外科，重庆 400016
- Keywords:
Thyroid cancer;
Hypocalcemia;
Hypoparathyroidism;
Hyperparathyroidism
- From:
Chinese Journal of Endocrine Surgery
2024;18(4):465-468
- CountryChina
- Language:Chinese
-
Abstract:
Surgery is the important treatment for each type of thyroid cancer. Single or multiple parathyroid injuries or blood supply disorders may occur during the operation, resulting in dramatic decline of parathyroid hormone and hypocalcemia after operation, which is common in clinical practice. After discharge, chronic hypocalcemia can cause great physical and psychological pain to patients. Although the residual parathyroid glands can compensate after surgery in some cases, long-term negative calcium balance and postoperative hypocalcemia may cause excessive hyperplasia of the residual parathyroid glands, resulting in parathyroid hyperfunction or even hyperparathyroidism, which can lead to osteoporosis, urinary calculi, metastatic vascular calcification, and systemic abnormal migratory calcium deposits. It’s advisable to enhance the awareness of the cause and harm of the postoperative hypocalcemia, evaluate and diagnose it early, and actively intervene in every stage of before, during and after the operation and long-term follow-up, which can effectively reduce the occurrence and severity of hypocalcemia and improve the postoperative life quality and the prognosis.
